Showing results (121-130 of 3,522) with videos related to

Sort By:
Pageof 353
Thoracic Cancer|May 13, 2020
CAPN1 promotes malignant behavior and erlotinib resistance mediated by phosphorylation of c-Met and PIK3R2 via degrading PTPN1 in lung adenocarcinomaYichuan Chen, Jingqun Tang, Ting Lu, et al.
Thoracic Cancer|May 15, 2020
Treatment with or without bevacizumab as a first-line and maintenance therapy for advanced non-squamous non-small cell lung cancer: A retrospective studyNi Jun, Wang Hanping, Si Xiaoyan, et al.
Thoracic Cancer|May 30, 2020
Brain cavernous hemangioma mimicking radiation-induced necrosis in a patient with non-small cell lung cancerShinkichi Takamori, Takashi Seto, Mikako Jinnouchi, et al.
Thoracic Cancer|May 30, 2020
Clinical recommendations on lung cancer management during the COVID-19 pandemicYan Xu, Hongsheng Liu, Ke Hu, et al.
Thoracic Cancer|May 9, 2020
Association between serum biomarkers CEA and LDH and response in advanced non-small cell lung cancer patients treated with platinum-based chemotherapyCorine de Jong, Vera H M Deneer, Johannes C Kelder, et al.
Thoracic Cancer|May 7, 2020
Outcomes of lobectomy on pulmonary function for early stage non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD)Sen Wei, Feng Chen, Renwang Liu, et al.
Thoracic Cancer|August 28, 2021
A novel lncRNA-miRNA-mRNA competing endogenous RNA regulatory network in lung adenocarcinoma and kidney renal papillary cell carcinomaQiwei Zhou, Diangeng Li, Hongying Zheng, et al.
Thoracic Cancer|August 18, 2021
Electromagnetic navigational bronchoscopy-guided dye marking to identify the subsegmental bronchus in thoracoscopic anatomic subsegmentectomyRongjian Xu, Min Zhao, Yandong Zhao, et al.
Thoracic Cancer|August 18, 2021
Immune-mediated thrombocytopenia induced with durvalumab after chemoradiotherapy in a non-small cell lung cancer patient: A case reportTomonori Makiguchi, Hisashi Tanaka, Kosuke Kamata, et al.
Thoracic Cancer|August 23, 2021
Tumor-associated macrophages (TAMs)-derived osteopontin (OPN) upregulates PD-L1 expression and predicts poor prognosis in non-small cell lung cancer (NSCLC)Yue Li, Hailin Liu, Yujie Zhao, et al.
Pageof 353